Who invested in Kinaset Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$103Mraised across 1 round since 2026, from 1 source

Latest round: Series B, $103MJan 2026
Investors: 4

See who backed them

The rounds

Jan 2026
Series B$103M
Source recorded

Founders and team

From Kinaset Therapeutics's own website and the SEC filings it signed: 1 founder, 4 on the team.

Frazer MorganChief Development Officer / Co-FounderNamed on its 2023 Form D

Robert ClarkeChief Executive Officeri
Anesa MoyerVice President of Clinical Operations
Roger HeermanChief Business Officer and Chief Operating Officeri
Christoph KocherPrincipal

On the board, as filediBram VanparysJamil BegKevin BittermanTom King

Everyone who backed them

RA Capital ManagementPrivate equity1round

5AM VenturesVC firm1round

Vivo CapitalPrivate equity1round

EQT Life SciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Kinaset Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.